Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc. · Fails to Deliver

Track AKBA — free
$0.88 -0.04 (-3.92%)
Market Cap
$244.05M
Shares
277.11M
Volume · Oct 1 4.51M Avg daily vol (3M) 6.05M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-09-14 1,314 $0.95 $1,248
2026-09-11 12,183 $0.95 $11,574
2026-09-10 3,707 $0.95 $3,522
2026-09-09 1,314 $1.03 $1,353
2026-09-08 1,314 $0.97 $1,275
2026-09-04 1,314 $0.98 $1,288
2026-09-03 1,314 $0.98 $1,288
2026-09-02 1,314 $0.94 $1,235
2026-09-01 2,009 $0.92 $1,848
2026-08-31 1,314 $0.88 $1,156
2026-08-28 2,798 $0.94 $2,630
2026-08-27 1,314 $0.91 $1,196
2026-08-26 132,627 $0.96 $127,322
2026-08-25 1,517 $0.90 $1,365
2026-08-24 1,517 $0.91 $1,380
2026-08-21 1,879 $0.92 $1,729
2026-08-20 1,517 $0.89 $1,350
2026-08-19 1,517 $0.85 $1,289
2026-08-18 1,517 $0.86 $1,305
2026-08-17 1,517 $0.87 $1,320
2026-08-14 1,517 $0.87 $1,320
2026-08-13 1,517 $0.89 $1,350
2026-08-12 1,517 $0.87 $1,320
2026-08-11 1,517 $0.84 $1,274
2026-08-10 6,467 $0.91 $5,885
2026-08-07 38,118 $0.95 $36,212
2026-08-06 1,517 $1.29 $1,957
2026-08-05 1,517 $1.32 $2,002
2026-08-04 15,796 $1.31 $20,693
2026-08-03 1,517 $1.32 $2,002
2026-07-31 1,517 $1.35 $2,048
2026-07-30 1,517 $1.26 $1,911
2026-07-29 1,517 $1.27 $1,927
2026-07-28 1,638 $1.28 $2,097
2026-07-27 1,638 $1.22 $1,998
2026-07-24 1,638 $1.22 $1,998
2026-07-23 13,008 $1.26 $16,390
2026-07-22 1,638 $1.30 $2,129
2026-07-21 1,638 $1.28 $2,097
2026-07-20 1,638 $1.34 $2,195
2026-07-17 15,265 $1.40 $21,371
2026-07-16 2,183 $1.38 $3,013
2026-07-15 1,638 $1.40 $2,293
2026-07-14 1,638 $1.38 $2,260
2026-07-13 1,638 $1.40 $2,293
2026-07-10 2,782 $1.43 $3,978
2026-07-09 1,638 $1.42 $2,326
2026-07-08 1,638 $1.36 $2,228
2026-07-07 1,638 $1.30 $2,129
2026-07-06 1,638 $1.24 $2,031
Showing 1–50 of 52 settlements
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 4 filings 4 filers Visit website Investor relations